J&J col­lab­o­rates with Aldeyra on new drugs for sys­temic in­flam­ma­to­ry dis­eases

A few months af­ter post­ing mid-stage da­ta sug­gest­ing that its lead drug could be on a path to prov­ing its worth in treat­ing var­i­ous con­di­tions …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.